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CONCISE COMMUNICATION
Risk of Mycobacterium tuberculosis transmission
in an antiretroviral therapy clinic
Themba Mzembea,b, Estelle Mcleana,b, Palwasha Y. Khanb,
Olivier Kooleb, Lifted Sichalia, Venance Mwinukaa, Michael Kayangec,
Peter Mzumarad, Andrew Dimbac, Amelia C. Crampina,b
and Judith R. Glynnb
Objective: The risk of transmission of Mycobacterium tuberculosis in antiretroviral
therapy (ART) clinics is recognized, particularly, when HIV and tuberculosis services
are unified, but the degree of potential exposure to patients with infectious tuberculosis
has not been measured. We aimed to quantify this clinic exposure.
Methods: Over 1 year, we recorded all visits to a clinic in northern Malawi that offers
HIV testing and counselling, HIV care, ART, and TB diagnostic and treatment services.
We included patients and guardians, noting timing and reason for the visit, using a palm
vein reader to assist recognition of individuals and record times automatically. Screen-
ing for tuberculosis was enhanced, including induced sputum if necessary.
Results: Information was collected on 5011 individuals and 19426 visits. During the
period, 90 individuals with bacteriologically confirmed pulmonary tuberculosis
attended the clinic when they were likely to have been infectious (taken as 6 weeks
before diagnosis to 2 weeks after the start of treatment), including 76 who attended
before tuberculosis was diagnosed or suspected. We estimated that 19% of visits had at
least 1 h of potential exposure to patients with infectious tuberculosis, half to patients
attending prediagnosis.
Conclusion: There was considerable risk of exposure, including of immunosuppressed
patients, to patients with infectious tuberculosis, especially as repeated visits are made.
Much of this exposure could not be avoided by separation of patients with known
tuberculosis. Good ventilation and avoidance of crowding is essential to minimize
transmission of M. tuberculosis in this type of setting.
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Introduction
HIV infection greatly increases the risk of tuberculosis
(TB), and even those established on antiretroviral therapy
(ART) remain at increased risk of TB compared with
people without HIV infection [1]. The proportion of
individuals initiating ARTwho have prevalent TB can be
very high [2,3]: for example, 8–18% in South Africa
[4–6]. Undiagnosed TB in those attending for ART, pre-
ART care, or HIV testing and counselling (HTC) poses a
risk of transmission to other clinic attendees. In addition,
patients already diagnosed with TB may continue to
attend general clinics for HTC or ART, adding to
potential exposure.
Countries with dual HIV–TB epidemics are exhorted
to integrate HIV and TB services to improve continuity
of care [7]. This includes physical integration of
facilities, further bringing together people with infec-
tious TB (with or without HIV) and people with
immunosuppression.
Although the risk of acquiring TB in HTC/ART clinics
is recognized, it has not been quantified. In northern
Malawi, we have shown that about 90% of Mycobacterium
tuberculosis transmission is from unknown contacts [8–10].
M. tuberculosis transmission is most likely to occur in
poorly ventilated indoor settings [11,12]. ART clinics are
settings where transmission from casual contacts is likely.
Clinics are held indoors and are frequently crowded,
reducing effective ventilation. In an HTC/ART/TB
clinic in a district hospital in Malawi, we measured clinic
exposure to infectious TB.
Methods
Between July 2014 and June 2015, we recorded all
attendances at the largest HTC/ART/TB clinic in
Karonga District, Malawi. The clinic is free-standing with
a single entrance, and rooms for HTC, HIV/ARTand TB
services (including collection and submission of sputum
containers for diagnosis, and monitoring, registration,
and drug dispensing). There are separate indoor waiting/
counselling areas designated for different services, but
patients mingle. All patients and their guardians attending
the clinic were eligible to participate in the study. At the
first visit, the study was explained and written informed
consent obtained. Parents/guardians gave consent for
children. Identifying information was collected, includ-
ing using a digital palm vein reader. At all visits, the reason
for the visit was collected, and attendees were asked to use
the palm vein reader on arrival and departure to aid
speedy recognition and automatically record the times of
clinic entry and exit.
We have been studying TB in Karonga District since
1986, with enhanced passive surveillance in clinics to
improve case finding in those with symptoms. For this
study, additional TB screening was carried out for patients
initiating ART, and those who had been on ART for
3 and 6 months, with a brief symptom screen [13], and
sputum collection (whether or not they were symptom-
atic), using a nebulizer (outside the clinic building) to
induce sputum if necessary. Sputum specimens were
processed at the hospital and the project laboratory in
Chilumba, Malawi. Sputum that was smear-negative at
the hospital was tested by GeneXpert. Positive cultures
were sent to the United Kingdom for species confirma-
tion. For those diagnosed with TB, smear and culture
results and treatment dates were recorded. The date of
diagnosis was taken as the collection date of the first
positive specimen, or the start of TB treatment if earlier.
Analyses describe time spent in the clinic by people
attending for different reasons. The extent of potential
exposure to TB was estimated from the duration of
overlap at the clinic with people with TB that was likely
to be infectious. This was taken as patients with
pulmonary TB that was bacteriologically confirmed
[i.e. sputum smear (if more than a single scanty smear) or
culture/GeneXpert positive], in the period between 6
weeks before diagnosis to 2 weeks after the start of
treatment, or for the entire treatment period if the
treatment outcome was ‘failure.’ To adjust for the lower
infectiousness of patients with smear-negative pulmonary
TB, the time overlap with these patients was divided by
10. As exposure to undiagnosed TB is hardest to avoid,
exposure to TB prediagnosis in patients not attending
because of suspected TB was examined separately. The
analysis was repeated considering only smear-positive TB
as infectious.
These estimates are deliberately conservative to estimate
minimum exposure: the average time from symptoms to
diagnosis is more than 6 weeks [14], and the time from
infectiousness onset to treatment will be longer; culture
positivity after treatment often persists beyond 2 weeks
even with drug-sensitive TB [15,16]; and the proportion
of transmission from smear-negative patients may be
more than 10% [17–19].
Approval for the study was given by the National Health
Sciences Research Committee, Malawi, and the ethics
committee of the London School of Hygiene & Tropical
Medicine, UK.
Results
During the study, 5011 individuals attended the clinic at
least once, contributing 19 426 visits. No study refusals
were noted, but a few people may have bypassed the
registration process. Visits for which entry or exit time was
missing (n¼ 3690) were taken as the median duration.
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Reasons for attendance
Of the attendees, 3186 (63.6%) were female patients. At
their first visit during the study, 250 (5.0%) attendees were
aged under 15 years, 3853 (76.9%) aged 15–49 and 906
(18.1%) aged over 50. Three thousand, eight hundred and
forty-six (76.8%) attendees were HIV-positive, 427
(8.5%) attended for HTC (but were not found to be
HIV positive), 601 (12.0%) attended only as a guardian/
caregiver (attending with a patient or to collect
medication), and 137 (2.7%) attended for other/
unknown reasons. Two hundred and fifty-one (5.0%)
attendees were known to be current TB patients and/or
gave TB as their reason for attending, including 60
initially attending because of suspected TB. Of 116
patients with bacteriologically confirmed TB, 26 only
attended the clinic after being on treatment for at least
2 weeks, but 90 (81 smear-positive, 9 smear-negative)
attended the clinic at least once in their ‘infectious’
period, including 76 who attended before TB was
diagnosed and who did not give suspected TB as the
reason for attendance.
Time spent in the clinic
The median time spent in the clinic per visit was 81 min
[interquartile range (IQR) 42–140], longer for those
already known to be HIV-positive (83, IQR 44–144),
guardians (72, IQR 42–127) and those attending for
HTC (72, IQR 42–107), and shorter for those with
bacteriologically confirmed TB (50, IQR 31–92), or
suspected TB (48, IQR 17–81).
Exposure to infectious tuberculosis
Overall, there were 18 595 visits by patients not recorded
as having had TB: 10 812 (58.1%) of these had no clinic
exposure to patients with infectious TB, and 3473
(18.7%) had at least 1 h of potential exposure (Table 1),
including 1768 (9.5%) with at least 1 h of potential
exposure to patients with undiagnosed infectious TB.
The distribution of exposure times is shown in Figure 1.
Regarding only smear-positive patients as infectious
made little difference to the results: 59.9% of visits had no
exposure and 18.6% had at least 1 h exposure (Table,
Supplemental Digital Content, http://links.lww.com/
QAD/B366).
Potential exposure was lower in children: 23.5% of visits
by children aged under 15 vs. 42.9% of visits by adults had
some exposure to infectious TB (chi-squared P< 0.001);
and in visits with exposure, median duration 42 min for
children vs. 52 min for adults, (Wilcoxon rank-sum test
P¼ 0.002). Visits by men were slightly more likely to
have some exposure to infectious TB than those by
women (44.4 vs. 40.6%, P< 0.001), but in exposed visits,
there was little difference between the exposure times
(median 50 min for men vs. 52 min for women, P¼ 0.8).
Prolonged exposure (over an hour) was more common
for those receiving HIV care (17.3%) and on ART
(19.2%) than for those receiving only HIV testing
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(12.0%), or attending as a guardian (15.9%, P< 0.001),
Table 1.
Many patients made multiple visits during the year of the
study (median 4, IQR 2–5, range 1–24). Over the year,
51.8% of attendees had a cumulative exposure to
infectious TB of at least 1 h, and 23.0% had at least 3 h
exposure. Considering only exposure to undiagnosed
infectious TB, 31.4% had a cumulative exposure of at least
1 h and 8.7% had exposure of at least 3 h.
Discussion
In this study in a busy ART clinic, we estimated that 42%
of visits had some potential exposure to patients with
infectious TB, and 19% of visits had prolonged exposure
(over an hour). Over the year, half the attendees had
cumulative potential exposure to infectious TB of an
hour or more.
To estimate exposure, we made conservative assumptions
about the infectious period. We made even more
conservative assumptions in the sensitivity analysis, which
only considers smear-positive patients as infectious. Even
with these assumptions, there is substantial potential
exposure.
In the study, we could only measure overlapping times, not
proximity of exposure. The presence of someone with
infectious TB in the clinic does not implyhigh exposure for
all patients attending at the same time. But the clinic is often
crowded with patients sitting close together on benches or
crowding in doorways, and ventilation is limited. Some
visits had considerable opportunities for exposure, and as
people attend repeatedly, the likelihood of actual exposure
is not negligible.
In this setting, children attend the clinic on a different day,
which explains their lower exposure, as most people with
infectious TB are adults. At the time of the study, HIV-
positive individuals initiating treatment were seen at the
end of the clinic, potentially increasing exposure, but this
policy has changed since test-and-treat started in
July 2016.
Exposure to infectious TB could theoretically be reduced
by separating those with known or suspected TB from
2420 AIDS 2018, Vol 32 No 16
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Fig. 1. Proportion of visits by minutes exposed to patients with infectious tuberculosis, showing those with at least 10 min
exposure. In addition, 64% of visits had less than 10min exposure to infectious TB and 80% had less than 10min exposure to
infectious TB prediagnosis. TB, tuberculosis.
other patients. Such separation is a ‘strong recommenda-
tion’ in the WHO guidelines [20]. However, about half of
the prolonged exposure was to undiagnosed TB (Table 1),
even though diagnostic delay in this setting was
minimized by enhanced screening. As some degree of
patient mixing is inevitable, the key public health
response is to try and reduce transmission, through good
ventilation, reducing waiting times and crowding, and
ensuring cough etiquette (covering the mouth, moving
outside) [20]. In a hot climate, natural ventilation with
open waiting areas, high ceilings and open windows on
opposite sides can be effective [21]. Simple administrative
measures could also help, for example, numbered tickets
to prevent people pushing forward to be seen, and to
allow them to wait outside if waiting times are prolonged.
There is increasing interest in documenting social mixing
patterns to improve understanding of the spread of
infections [22]. We have used novel methods to
characterize mixing with patients with infectious TB
in an HTC/ART clinic, where the presence of
immunosuppressed patients makes the consequences of
exposure to infection particularly dangerous. The patient
mix and experience in this clinic are likely to be typical of
many HTC/ART clinics in sub-Saharan Africa. We have
quantified the high potential for exposure to infectious
TB, much of which was from patients with undiagnosed
TB. Good ventilation and systems to avoid crowding are
essential to minimize the risk of M. tuberculosis transmis-
sion in such settings.
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